• Itepekimab Reduces Loss of Asthma Control

    1 month ago - By Medscape

    Treatment with itepekimab, a new human IgG4P monoclonal antibody against interleukin-33, led to a reduction in events indicating loss of asthma control.
    Medscape Medical News
    Read more ...

     

  • Itepekimab lowers events indicating loss of asthma control, improves lung function

    Itepekimab lowers events indicating loss of asthma control, improves lung function

    1 month ago - By Healio

    Treatment with itepekimab resulted in a lower incidence of events indicating loss of asthma control and improved lung function in adults with moderate to severe asthma, according to new phase 2 data.
    The phase 2, randomized, double-blind, placebo-controlled, proof-of-concept trial published in The New England Journal of Medicine included 296 adults with moderate to severe asthma who were receiving inhaled glucocorticoids plus long-acting beta agonists. Patients were randomly assigned subcutaneous itepekimab 300 mg , dupilumab 300 mg
    Read more ...